Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Prepaid Assets (2016 - 2025)

Guided Therapeutics (GTHP) has disclosed Prepaid Assets for 16 consecutive years, with $90000.0 as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 47.98% to $90000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $90000.0 through Dec 2025, down 47.98% year-over-year, with the annual reading at $90000.0 for FY2025, 47.98% down from the prior year.
  • Prepaid Assets hit $90000.0 in Q4 2025 for Guided Therapeutics, down from $123000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $453000.0 in Q1 2022 to a low of $23000.0 in Q2 2025.
  • Historically, Prepaid Assets has averaged $149200.0 across 5 years, with a median of $130000.0 in 2022.
  • Biggest five-year swings in Prepaid Assets: surged 1061.54% in 2022 and later plummeted 79.46% in 2025.
  • Year by year, Prepaid Assets stood at $377000.0 in 2021, then tumbled by 63.66% to $137000.0 in 2022, then increased by 18.98% to $163000.0 in 2023, then increased by 6.13% to $173000.0 in 2024, then crashed by 47.98% to $90000.0 in 2025.
  • Business Quant data shows Prepaid Assets for GTHP at $90000.0 in Q4 2025, $123000.0 in Q3 2025, and $23000.0 in Q2 2025.